Breast Cancer Congress

Understanding resistance to targeted therapies in head and neck, breast cancer MSN highlights University of Cincinnati Cancer Center research

. MSN features UC Cancer Center's research on why head, neck, and breast cancers resist targeted therapies, aiming to improve treatment outcomes.Readmore

Barriers keeping breast cancer patients out of clinical trials

Many breast cancer patients face barriers like lack of awareness, access issues, and strict eligibility criteria, keeping them out of vital clinical trials.Readmore

Scientists uncover new approach for targeting aggressive breast cancer

Scientists have discovered a promising new strategy to target aggressive breast cancer, offering hope for more effective treatments and improved patient outcomes.Readmore

Oregon State University researchers discover novel way to make breast cancer cells die

Oregon State University researchers have discovered compounds that convert a protein known for protecting cancer cells into a tumor killer.Readmore

UT Dallas Study Tests AI as a Triage Tool in Breast Cancer Screenings

Artificial intelligence can be a useful tool in identifying high-risk breast cancer cases, allowing for quicker reviews by radiologists, according to two information systems professors at the University of Texas at Dallas.Readmore

Researchers Aim to Adapt Metastatic Breast Cancer Therapy as Tumors Change

Yale researchers are part of a collaboration developing an “evolutionary” approach to treating metastatic breast cancer, in which therapy choices are adapted as patients’ cancer changes.Readmore

New radiotracer could make breast cancer detection quicker, more accurate

A new radiotracer developed at the University of Alberta and soon to be tested in human clinical trials in Europe could make medical imaging of breast cancer tumors quicker and more accurate, and could one day lead to better treatments. Readmore

Breast cancer risk in younger women may be influenced by hormone therapy

NIH study could help to guide clinical recommendations for hormone therapy use among women under 55 years old.Readmore

Study Lays Groundwork for Precision Treatment of HR+/HER2- Breast Cancer

Roswell Park investigators uncover evidence that could help make CDK4/6 inhibitors more effectiveReadmore

determining Obesity's Role in Triple-Negative Breast Cancer

Breast cancer remains the most commonly diagnosed cancer among women globally. In 2023, the U.S. saw approximately 297,790 new invasive cases in women, highlighting its ongoing public health impact due to high incidence and mortality rates.Readmore

Study: Quick, pain-free breast imaging system shows promise in early clinical tests

Automated scan takes less than a minute and produces AI-powered, clear 3D imagesReadmore

UAB offers new minimally invasive treatment option for breast cancer patients

UAB introduces a new minimally invasive treatment for breast cancer, offering patients a safer and faster recovery with advanced targeted therapy.Readmore

New study reveals promising strategy to retrain neutrophils to target breast cancer

Innovative strategy has the potential to revolutionize the treatment of breast cancer, particularly for patients who have developed resistance to targeted therapies Readmore

SAU professor conducting research on fighting breast cancer

“The nanoparticles are small enough to get inside a cell and cause damage to a cancer cell,” said Showalter.Readmore

New Queen's study will investigate why a DNA change is linked to breast cancer

Researchers funded by Breast Cancer Now are investigating how a specific DNA change raises breast cancer risk—especially why it affects men more than women.Readmore

Beyond the mammogram: Study finds differences between benign and cancerous breast calcifications

Illinois researchers found distinct patterns in breast calcifications, with cancerous ones showing tightly clumped calcium phosphate nodules coated in thick layers. Readmore

Powering off cancer: Slowing down the spread of aggressive breast cancers by targeting their cellular powerhouse

Canadian researchers found that boosting mitochondrial fusion may slow breast cancer spread, with the arthritis drug leflunomide showing promise in early studies. Readmore

Women of African ancestry may be biologically predisposed to early onset or aggressive breast cancers

Black women are more likely to develop aggressive breast cancer subtypes, such as triple-negative. Among women under 50, their mortality rate is twice that of white women. This highlights the need for improved early detection and treatment equity.Readmore

Breast Cancer Drug Supinoxin Shows Potential for Small-cell Lung Cancer Treatment in New Tests

Supinoxin, a breast cancer drug, shows promise in treating small-cell lung cancer, according to new test results.Readmore

New discovery could halt secondary breast cancer growth

Scientists at the Cancer Research UK Scotland Institute, based at the University of Glasgow, have made a discovery which could help stop the spread of breast cancer – one of the leading causes of death from the disease.Readmore

Respiratory Viruses Can Wake Up Breast Cancer Cells in Lungs

Researchers uncover first direct evidence that respiratory infections can awaken dormant breast cancer cells, setting the stage for new metastatic tumorsReadmore

UMass Chan MD/PhD student Ayush Kumar wins AMA Research Challenge

Ayush Kumar won first prize for research on enhancing radiosensitivity in triple-negative breast cancer using targeted antibodies.Readmore

Omega-6 fatty acid promotes growth of aggressive type of breast cancer

Researchers found that linoleic acid activates a key growth pathway in triple-negative breast cancer by binding to FABP5.Readmore

New Risk Prediction Model Shows Promise for Early Breast Cancer Detection

Breast cancer risk prediction helps identify women for prevention or early detection, with early diagnosis greatly improving outcomes.Readmore

New “Smart” Immune Cells: A Breakthrough for Long-Lasting Tumor Destruction

USC Viterbi researchers have engineered a new immune cell that when activated by ultrasound can continuously sense and destroy cancer cells for extended periods.Readmore

Uncovering Mechanisms Driving Estrogen Receptor-Negative Breast Cancer

Northwestern Medicine investigators have discovered previously unknown metabolic changes that may contribute to the development of estrogen receptor–negative breast cancer.Readmore

Physical training has a positive effect on the sexual health of women with metastatic breast cancer

A study showed that a nine-month supervised exercise program significantly reduced symptoms, including sexual issues, in women with metastatic breast cancer.Readmore

The search for biological targets to halt breast cancer metastasis

Biological mechanisms allowing a cancer cell from one part of the body to successfully grow in another part.Readmore

New research on common breast cancer that is resistant to hormone therapies

Promising new approach developed for overcoming treatment resistance in oestrogen receptor-positive (ER+) breast cancerReadmore

BOOSTING BREAST CANCER RADIOTHERAPY WITH VALPROIC ACID ANALOGUES

Breast cancer treatment with radiotherapy can both enhance anti-tumor immunity and, paradoxically, promote immune evasion leading to recurrence.Readmore

Black Women in Underserved Areas Face Greater Risk of Dying from Breast Cancer

Black women who live in disadvantaged neighborhoods experience higher breast cancer mortality risk.Readmore

MSU researchers use ‘smart’ bomb therapy to destroy breast cancer

These new chemicals offer targeted cancer therapy with fewer side effects, sparing healthy cells. They clear from the body quickly, reducing sun sensitivity and expanding use to other cancers.Readmore

American Cancer Society grant fuels MSU research in colorectal, breast and cervical cancer

Cancer is a leading driver of U.S. healthcare costs, totaling around $222 billion annually. Prevention through screening and safer, effective treatments can reduce side effects and improve survival.Readmore

New imaging technology helps Stanford Medicine surgeons reduce repeat breast surgeries

Stanford Medicine breast surgeons are the first in the country to use a new technology that lights up cancer cells left behind when a tumor is removed.Readmore

‘AI scientist’ suggests combinations of widely available non-cancer drugs can kill cancer cells

An AI-powered scientist, teaming up with human researchers, has identified affordable, safe drug combinations with potential to treat cancer.Readmore

UM research team discovers new method to inhibit triple-negative breast cancer

UM research team has developed a new method to inhibit triple-negative breast cancer. This approach offers hope for treating one of the most aggressive breast cancer types.Readmore

Metastatic breast cancer study receives up to $28 million

This cluster of circulating tumor cells (shown in red) and white blood cells (shown in green) originated from the blood of a breast cancer patient. (Submitted photo; Graphic by Gillie Sibrian/UNC-Chapel Hill)Readmore

AIMRC Awarded Supplement to Explore Obesity's Impact on Nerve Growth in Breast Tumors

The Arkansas Integrative Metabolic Research Center received a $263,813 NIH grant to study how obesity-induced tissue changes impact nerve growth in breast tumors.Readmore

Too few women who pause breast cancer treatment during pregnancy resume therapy after delivery

Stanford Medicine-led research found that only one-third of women who pause hormone therapy to become pregnant resumed treatment and that the rates of recurrence in this population were doubled.Readmore

Breast cancers broadly defined by their genome architecture in Stanford Medicine study

Breast cancers at all stages are defined by the structure of their genomes, Stanford Medicine researchers find. Targeting these processes early is likely to offer unexpected therapeutic avenues.Readmore

A new insight into the mechanism of breast cancer migration

Researchers at Cardiff University’s School of Pharmacy and Pharmaceutical Sciences, in collaboration with the University of Dundee, have provided new clues into the mechanisms by which breast cancer migrates around the body.Readmore

New Buffett Taylor Chair in Breast Cancer Research returns to HHS roots

The return of renowned breast cancer physician and researcher Dr. Andrea Eisen to Hamilton Health Sciences (HHS) is being celebrated by the hospital’s medical, research, innovation and teaching communities.Readmore

New NIH Grant to Fight Triple-Negative Breast Cancer

With support from the NIH, Assistant Professor Quanyin Hu uses a two-step system to attack triple-negative breast cancerReadmore

Nanotechnology could improve odds in treating aggressive breast cancers

University of Queensland researchers are designing nanotechnology they believe could improve how we treat the most aggressive form of breast cancer.Readmore

BreastScreen campaign targets underscreened women

Breast Screen NSW has relaunched a campaign encouraging women to have a life saving mammogram and join the 15, 000 women who screened across Nepean Blue Mountains Local Health District in 2024.Readmore

Delay of More Than 42 Days for Breast Cancer Surgery Raises Death Risk for Certain Subtypes, University of Oklahoma Study Finds

OKLAHOMA CITY, OKLA. – Patients with certain subtypes of breast cancer may face a higher risk of death from the cancer if they wait more than 42 days after diagnosis to have surgery, according to newly published research from the University of Oklahoma.Readmore

Delaying breast cancer surgery beyond 42 days increases death risk for certain subtypes, per University of Oklahoma study.

Patients with certain breast cancer subtypes face higher death risk if surgery is delayed over 42 days, per University of Oklahoma study.Readmore

Using breast milk to understand the mammary gland

She developed a human mammary gland organoid and ‘organ-on-a-chip’ technology from donated milk to study how mammary gland cells functionReadmore

Breast Cancer Survivors With BRCA Mutation Have Higher Risk of Second Cancer

People with a BRCA1 or BRCA2 mutation with a history of breast cancer have a higher risk of developing a second primary cancer than people without the mutation, according to a study in The Journal of Clinical Oncology.Readmore

UNMC researchers identify key protein in breast cancer brain metastasis

UNMC researchers have identified a key protein whose increased presence helps promote breast cancer brain metastasis, opening a new area of research into the dire condition.Readmore

AIBN researchers receive $3M to target deadly breast cancer

University of Queensland researchers are developing next-gen nanoparticles to enhance treatments for triple-negative breast cancer. Their work aims to improve outcomes against this aggressive disease.Readmore

Three out of ten breast cancer cases are detected between screening sessions

A Karolinska Institutet study in JAMA Oncology highlights interval breast cancer as a significant portion of cases, influenced by specific risk factors.Readmore

ECU study finds exercise could reduce breast cancer recurrence

Exercise could potentially reduce the recurrence rate of breast cancer, new research from Edith Cowan University (ECU) has found.Readmore

Surgery may not be necessary to treat invasive breast cancer

MD Anderson researchers suggest surgery may be unnecessary for early-stage breast cancer patients who fully respond to neoadjuvant chemotherapy and radiation.Readmore

New study confirms hormone’s role in post-menopausal breast cancer risk

A major study confirms that a hormone regulating breast development increases breast cancer risk in postmenopausal women.Readmore

MD Anderson Study Questions Need for Breast Cancer Surgery in Select Patients

Researchers at MD Anderson Cancer Center found that women with a complete response to neoadjuvant systemic therapy had excellent five-year outcomes without surgery, suggesting selective surgery avoidance may be feasible.Readmore

New study confirms hormone’s role in post-menopausal breast cancer risk

A major study confirms that a breast-regulating hormone increases postmenopausal breast cancer risk.Readmore

Breast cancer research with global impact

BRCA1/2 mutations impair DNA repair, raising breast, ovarian, prostate, and pancreatic cancer risk, affecting 1 in 200–300 people.Readmore

Connie Dwyer Breast Cancer Foundation Grant Highlights

Nearly $100,000 has been granted to eight organizations, aiding over 7,000 breast cancer patients and their families.Readmore

CDC Grant Funds Initiatives for Breast Cancer Patients

Weill Cornell Medicine has received a five-year, 2.3 million dollar grant from the Centers for Disease Control and Prevention to improve equitable access to care, quality of life and survival outcomes for young people with all stages of breast cancer.Readmore

Study in multiancestry populations uncovers new insights into breast cancer genetics

Results of an ambitious study that fine-mapped 192 genomic regions where breast cancer risk variants are located in women of European, African and Asian ancestry has yielded new understanding of the genetics and biology of this common cancer.Readmore

Houston Methodist Researchers Pioneer New Treatment Strategies for Metaplastic Breast Cancer

Houston Methodist Hospital researchers have identified a promising therapeutic approach for metaplastic breast cancer, a rare and aggressive subtype of triple-negative breast cancer with the worst prognosis among all breast cancers globally.Readmore

Uncovering inequalities in breast cancer immunotherapy access

Triple-negative breast cancer (TNBC) is an aggressive form of the disease that accounts for 15% of all breast cancer cases. Black women are twice as likely as white women to be diagnosed with TNBC and 28 percent more likely to die from it.Readmore

Building better biomaterials for cancer treatments

Altering the physical properties of microscopic biomaterials to better integrate with body tissues could lead to safer, more effective cancer treatments, say Virginia Tech researchers.Readmore

Scientists discover the ‘roadmap’ that aggressive cancer uses to spread around the body and identify ways to block its escape

Researchers have found a way to predict which tumors will become aggressive before spreading, helping doctors detect high-risk cases early and explore new treatment options.Readmore

AI-Based Mammography Offers Potential for Early Detection of Breast Cancer

Breast cancer is increasing and often detected late due to unnoticed early stages and limited screening. It is the most common cancer in women, accounting for 11.6% of cases worldwide.Readmore

Moffitt Study Identifies Immune Response That May Stop Breast Cancer from Spreading

A Moffitt Cancer Center study found that activating certain immune cells can prevent dormant breast cancer cells from forming new tumors.Readmore

The Pfizer Foundation Provides $15 Million Investment to Improve Breast Cancer Care in Sub-Saharan Africa

The Pfizer Foundation launched a $15 million initiative to improve breast cancer care in Rwanda, Ghana, and Tanzania, partnering with Jhpiego and Partners In Health to support local health efforts.Readmore

Breast Cancer Canada’s Path for 2025: Prioritizing Early Detection, Timely Access, and Breakthrough Research

Breast Cancer Canada advances research, advocates for equity, and supports patients, striving for better outcomes in 2025.Readmore

Breast cancer treatment advances with light-activated ‘smart bomb’

Scientists have developed new light-sensitive chemicals that can radically improve the treatment of aggressive cancers with minimal side effects. In mouse tests, the new therapy completely eradicated metastatic breast cancer tumors.Readmore

World-leading AI trial to tackle breast cancer launched

Nearly 700,000 women will join a major trial testing AI for early breast cancer detection.Readmore

One Chemo Medicine Before Surgery for Early-Stage HER2-Positive Breast Cancer May Be Better Than Two

Abraxane before surgery may improve outcomes for early-stage HER2-positive breast cancer patients compared to Taxotere and carboplatin.Readmore

Why Should I Choose Digital Mammography for Breast Cancer Screening in Buffalo, NY?

Digital mammography captures high-resolution X-ray images of the breast electronically, allowing for enhanced viewing and manipulation. This improves detection of abnormalities with greater precision than traditional film mammography.Readmore

Innovative dual-target drug may lead to new investigational approach for breast cancer patients

Professor Laura Mackay's team at the University of Melbourne, in collaboration with Pfizer, uncovered potential future breast cancer treatments.Readmore

Enhertu recommended for approval in the EU by CHMP for patients with HER2-low or HER2-ultralow metastatic breast cancer following at least one endocrine therapy

Recommendation based on DESTINY-Breast06 Phase III trial results which showed Enhertu demonstrated superiority vs. chemotherapy with a median progression-free survival of more than one yearReadmore

Stay Brave, Stay Beautiful: 2025 Paint the Pink Ambassador Breanna Bortner Shares Her Story

By August 2022, when Breanna Bortner moved to Austin with her husband and cockapoo, Mochi, she was already a longtime attendee of Paint the Town Pink, previously traveling six hours to join friends.Readmore

Cancer Center study identifies potential new target to overcome breast cancer resistance

The Cancer Center’s Xiaoting Zhang, PhD, said antiestrogen therapy is used for about 75% of breast cancers, but relapse and treatment resistance occur in about half of these patients at some point.Readmore

£1 million funding boost for research into preventing breast cancer recurrence

Researchers working to understand why some breast cancers come back years later and form incurable secondary tumours, have received a £1 million funding boost. Readmore

Oxytocin system of breastfeeding affected in mothers with postnatal depression

The oxytocin system – which helps release breast milk and strengthens the bond between mother and baby – may be affected during breastfeeding in mothers experiencing postnatal depression, finds a new study by UCL researchers.Readmore

Breast Cancer Treatment Supinoxin Be Effective for Small-Cell Lung Cancer, Study Finds

Small-cell lung cancer is tough to treat, said Elizabeth Tran, biochemistry professor. Though only 15% of lung cancer cases, it causes 250,000 deaths globally each year.Readmore

KU Cancer Center researcher identifies triple-negative breast cancer biomarker

With pilot funding from Alison’s Allies, Joan Lewis-Wambi and her research team have identified a protein overexpressed in triple-negative breast cancer in African American women.Readmore

What turns breast cancer cells aggressive? Chinese team may have found the key

Findings could open up new avenue for precision therapy for the most commonly diagnosed cancer among women that killed 670,000 in 2022 aloneReadmore

Sound Wave Research for Breast Cancer Receives $5.5 Million

Focused ultrasound pioneer Natasha D. Sheybani, PhD, has received $5.5 million to use focused sound waves to improve the immune system’s ability to battle breast cancer.Readmore